About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Sandra Susanibar-Adaniya
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Sandra Susanibar-Adaniya
0 views
March 13, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
01:29
Incyte
Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Recommended
AUTOPLAY
ON
Related
Newest
20:17
Indy Hematology Review
Managing Amyloidosis in 2024: Diagnosis and Treatment
Feat.
M. Gertz
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
13:43
Houston Methodist Hospital
Lung Involvement in Amyloidosis
Feat.
H. Huang
15:36
Memorial Sloan Kettering Cancer Center
Key Myeloma & MGUS Updates From ASH
Feat.
S. Mailankody
27:11
MyCancerHaven
POEMS Syndrome Management
Feat.
R. Vij,
D. Dingli
04:15
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…
Feat.
M. Gertz
10:25
Morie Gertz
"You Have AL-Amyloidosis": Counseling Newly Diagnosed Pati…
19:39
Yale Cancer Center
AL Amyloidosis Treatment Updates
Feat.
T. Parker
41:54
University of Colorado Division of Hematology
Overview of Pathophysiology, Diagnosis and Management of Multiple My…
Feat.
K. Sidor
21:03
Yale Cancer Center
Renal AL Amyloid
Feat.
R. Luciano
10:23
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …
Feat.
T. Einarsson Long
26:56
Dana-Farber Cancer Institute
Updates on AL Amyloidosis Treatment: What’s New in 2024
Feat.
G. Bianchi
27:05
American Society of Nuclear Cardiology
Interpreting a PYP Study for TTR Cardiac Amyloid
Feat.
P. Soman,
M. Harinstein,
S. Divakaran
27:26
Houston Methodist Hospital
FDA Perspective on New Therapies for Amyloidosis
Feat.
R. Adigun
18:06
MyCancerHaven
Experts Discuss Novel Antibodies for the Management of Amyloidosis
Feat.
R. Vij,
S. Lentzsch
19:10
Houston Methodist Hospital
Amyloidosis: Pathophysiology
Feat.
S. Ganguly
19:35
Dana-Farber Cancer Institute
Updates in the Management of SMM/MGUS and the Prevention of Progress…
Feat.
Y. Liu
12:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed …
Feat.
E. Kastritis
30:34
Houston Methodist Hospital
Current Treatment Options for AL Amyloidosis
Feat.
K. Baker
